期刊文献+

免疫去除血清高丰度蛋白对组织蛋白质组鉴定的影响

Impact of immunodepletion of serum high abundant protein on tissue proteome identification
下载PDF
导出
摘要 目的分析去除组织中血清高丰度蛋白对组织蛋白质组鉴定的影响。方法用去除12种血清高丰度蛋白抗体柱处理人甲状腺和垂体组织样品,所得到的低丰度蛋白和原样分别进行液质联用分析,分别进行多肽和蛋白质水平的定性定量分析。结果甲状腺和垂体组织中血清高丰度蛋白分别被除去了92.11%±12.87%和78%±25%。所鉴定到的多肽和蛋白与原样品相比,甲状腺组织的非冗余性多肽提高了70%、蛋白数目提高了16.5%,垂体的非冗余性多肽提高了21.9%,鉴定蛋白数目无明显变化。结论去除组织中的血清高丰度蛋白法可以显著的提高肽段和蛋白的鉴定效率,更适用于血管密集的样品。 Objective To analyze the impact of immunodepletion of serum high abundant protein on identification of tis- sue proteome. Methods Human thyroid and pituitary samples were disposed using 12 high abundant protein depletion antibody column. The low abundant proteins and raw samples were analyzed by I_E/MS. Identified peptides and proteins were qualitatively and quantitatively analyzed. Results The serum high abundant proteins in thyroid and pituitary were depleted by 92. 11% + 12. 87%, 78% ~25% respectively. Compared with raw thyroid, the non-redundant peptide and protein identification of low abundant thyroid were respectively increased by 70%, 16. 5%. The non-redundant peptide identification of low abundant pituitary was 21.9% higher than that of raw samples. But the protein identification was profile unchanged. Conclusions The immunedepletion of serum high abundant proteins can significantly improve pep- tide and protein identification and is more suitable for the tissues with intensive blood vessel.
出处 《基础医学与临床》 CSCD 2015年第4期439-443,共5页 Basic and Clinical Medicine
基金 国家重点基础研究发展计划(2013CB530805 2014CBA02005) 中国科技部重点基础研究计划(2013FY114100)
关键词 甲状腺蛋白质组 垂体蛋白质组 去除血清高丰度蛋白 液质联用分析 thyroid proteome pituitary proteome serum high abundant protein immunodepletion LC/MS analysis
  • 相关文献

参考文献1

二级参考文献11

  • 1Lay-Chin Yeoh,Chee-Keat Loh,Boon-Hui Gooi,Manjit Singh,Lay-Harn Gam.Hydrophobic protein in colorectal cancer in relation to tumor stages and grades[J].World Journal of Gastroenterology,2010,16(22):2754-2763. 被引量:3
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3J. Ferlay,E. Steliarova-Foucher,J. Lortet-Tieulent,S. Rosso,J.W.W. Coebergh,H. Comber,D. Forman,F. Bray.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012[J]. European Journal of Cancer . 2013 (6)
  • 4Nai-Jun Fan,Chun-Fang Gao,Xiu-Li Wang,Guang Zhao,Qing-Yin Liu,Yuan-Yao Zhang,Bao-Guo Cheng,Saulius Butenas.Serum Peptidome Patterns of Colorectal Cancer Based on MagneticBead Separation and MALDI-TOF Mass Spectrometry Analysis[J]. <journal-title>Journal of Biomedicine and Biotechnology . 2012
  • 5Rui Zhou,Wenjun Huang,Yuqin Yao,Yuxi Wang,Ziqiang Li,Bin Shao,Jian Zhong,Minghai Tang,Shufang Liang,Xia Zhao,Aiping Tong,Jinliang Yang.CA II, a potential biomarker by proteomic analysis, exerts significantinhibitory effect on the growth of colorectal cancer cells[J].International Journal of Oncology.2013(2)
  • 6Qifeng Lin,Hwee Tong Tan,Hannah Soo Rei Lim,Maxey C.M. Chung.Sieving through the cancer secretome[J].BBA - Proteins and Proteomics.2013
  • 7Dexiang Zhu,Yunshi Zhong,Haifu Wu,Lechi Ye,Jie Wang,Yan Li,Ye Wei,Li Ren,Bin Xu,Jianmin Xu,Xinyu Qin.Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting[J].Journal of Surgical Research.2013
  • 8Dexiang Zhu,Jie Wang,Li Ren,Yan Li,Bin Xu,Ye Wei,Yunshi Zhong,Xinzhe Yu,Shenyong Zhai,Jianmin Xu,Xinyu Qin.Serum proteomic profiling for the early diagnosis of colorectal cancer[J].J Cell Biochem.2012(2)
  • 9Yutaka Sugihara,Hirokazu Taniguchi,Ryoji Kushima,Hitoshi Tsuda,Daisuke Kubota,Hiroshi Ichikawa,Kano Sakamoto,Yukiko Nakamura,Takeshi Tomonaga,Shin Fujita,Tadashi Kondo.Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer[J].Journal of Proteomics.2012(17)
  • 10Hee-Young Yang,Joseph Kwon,Hyang-Rim Park,Sang-Oh Kwon,Young-Kyu Park,Hyung-Seok Kim,Yun-Jo Chung,Yu-Jung Chang,Hoon-In Choi,Kyoung-Jin Chung,Dong-Seok Lee,Byung-Ju Park,Sang-Hun Jeong,Tae-Hoon Lee.Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients[J].Journal of Proteomics.2012(12)

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部